Sarah F Aitken - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Sarah F Aitken

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Journal of Dental Education|September 8, 2020

Early pathways to research at the NIHSarah F Aitken, David A Cruz Walma, Omar D Glover, et al.

Journal of Molecular Biology|November 14, 2021

Differential Activity of APOBEC3F, APOBEC3G, and APOBEC3H in the Restriction of HIV-2Morgan E Meissner, Nora A Willkomm, Jamie Lucas, et al.

Developmental Dynamics : an Official Publication of the American Association of Anatomists|July 12, 2023

Infigratinib, a selective FGFR1-3 tyrosine kinase inhibitor, alters dentoalveolar development at high dosesZachary D Michel, Sarah F Aitken, Omar D Glover, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Journal of Dental Education|September 8, 2020

Early pathways to research at the NIHSarah F Aitken, David A Cruz Walma, Omar D Glover, et al.

Journal of Molecular Biology|November 14, 2021

Differential Activity of APOBEC3F, APOBEC3G, and APOBEC3H in the Restriction of HIV-2Morgan E Meissner, Nora A Willkomm, Jamie Lucas, et al.

Developmental Dynamics : an Official Publication of the American Association of Anatomists|July 12, 2023

Infigratinib, a selective FGFR1-3 tyrosine kinase inhibitor, alters dentoalveolar development at high dosesZachary D Michel, Sarah F Aitken, Omar D Glover, et al.

Pageof 1